Skip to main content
SHPH
NASDAQ Life Sciences

10% Owner HRT Financial LP Buys $30K of SHPH Stock, Boosting Stake

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.99
Mkt Cap
$1.905M
52W Low
$2.71
52W High
$55.9
52W Position info
10% above low
Off High info
95% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

SHPH is trading near its 52-week low of $2.71 (10% above the low) on light trading volume (0.1× avg).

Summary

10% owner HRT Financial LP bought $30,212 worth of SHPH shares on the open market, increasing its stake to 61,271 shares. The purchase represents 1.6% of the company's market cap, a notable commitment for a super-nano cap firm navigating a strategic transformation.


Key Events · Ownership and Investor Activity · SHPH

  • 10% Owner Buys $30K in Open Market

    HRT Financial LP acquired 8,997 shares for $30,212.49 at prices between $3.11 and $3.38 on July 9-10, 2026, increasing its total holdings to 61,271 shares.

  • Transaction Represents 1.6% of Market Cap

    The $30,212 purchase equals 1.6% of SHPH's $1.9M market cap, a significant commitment for a super-nano cap company.

  • Post-Reverse Split Accumulation

    The purchase follows a 1-for-10 reverse stock split on June 11, 2026, and the company's pivot to Dogecoin mining, with a going concern warning still in effect.


Analysis · SHPH · Life Sciences

HRT Financial LP, a 10% owner, purchased 8,997 shares for $30,212.49 on July 9-10, 2026, at prices between $3.11 and $3.38. This open-market buy increases its holdings to 61,271 shares. While the dollar amount is modest, the transaction represents a notable 1.6% of the company's tiny $1.9M market cap, signaling conviction from a significant shareholder. The purchase comes after a reverse stock split in June 2026 and amid a strategic pivot to Dogecoin mining, with the company still under a going concern warning. For a super-nano cap stock, this insider accumulation is a positive signal, though the 10% owner role tempers the impact slightly compared to a CEO purchase.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 30.2% of the 1943 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SHPH was trading at $2.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9M. The 52-week trading range was $2.71 to $55.90. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SHPH - Latest Insights

SHPH
Sep 11, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.42
Real-time Price: $3.53 info
Change: +$0.110 (+3%) info
Market Cap: $2.249M info
SHPH
Aug 28, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.54
Real-time Price: $3.53 info
Change: -$0.010 (-0.28%) info
Market Cap: $2.249M info
SHPH
Aug 13, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $4.58
Real-time Price: $3.53 info
Change: -$1.05 (-23%) info
Market Cap: $2.249M info
SHPH
Aug 03, 2026, 5:15 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $3.39
Real-time Price: $3.53 info
Change: +$0.1359 (+4%) info
Market Cap: $2.249M info
SHPH
Jul 01, 2026, 7:17 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $3.28
Real-time Price: $3.53 info
Change: +$0.2531 (+8%) info
Market Cap: $2.249M info